Research funder · United States
Congressionally Directed Medical Research Programs
Government organization in United States of America
- Grants since 2016
- 10.2k
- Awarded, last 5 years (where amounts are published)
- $6.5B
- Funded works, last 5 years
- 3 662
- Funded works, all time
- 7 320
Grants
2023–2026 · grant · ALSRP
Development of a Novel Treatment Strategy and Unique Methods of Delivery to the CNS for Amyotrophic Lateral Sclerosis
Sarah Rea · Murdoch University
2023–2027 · grant · LRP
Screening for Autoantibody-Producing Cells
Carol Webb · Oklahoma, University Of, Health Sciences Center
2023–2025 · grant · PCRP
Dissecting Translational Dynamics and Lineage Plasticity in Prostate Cancer
Yeon Soo Kim · Fred Hutchinson Cancer Center
2023–2026 · grant · ORP
Injectable Myoblast Scaffold to Regenerate Chronically Denervated Muscle
Sami Tuffaha · Johns Hopkins University
2023–2027 · grant · OCRP
Development of New Therapeutic Strategies of Chemobrain for Ovarian Cancer Survivors
Mi-Hyeon Jang · Rutgers, New Jersey, State University Of
2023–2026 · grant · NFRP
Interrogating Tumor-Immune-Neuron Cross Talk at Single-Cell Resolution in a Panel of Novel Somatic Transgenic NF1 Tumor Models
Yuan Pan · M.d. Anderson Cancer Center, University Of Texas
2023–2027 · grant · JWMRP
Remote Frostbite Detector (RFD)
Michele Pierro · Vivonics (United States)
2023–2027 · grant · MRP
From Predisposing Genetic Variants to Public (Shared) Tumor-Specific Neoantigens in Uveal Melanoma
Marc-Henri Stern · Institut Curie
2023–2026 · grant · PCRP
Therapeutic Targeting of Aurora Kinase A in Lethal Prostate Cancer Using a Novel Inhibitor
Jindan Yu · Emory University
2023–2026 · grant · TBIPH
Point-of-Injury Intranasal ALM Drug Therapy to Reduce Secondary Injury and Improve Outcomes After TBI in Civilian and Military Resource-Limited Environments
Geoffrey Dobson · James Cook University
2023–2027 · grant · PRMRP
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study of Single or Repeated Intravenous Administration of UC-MSCs in Ischemic Cardiomyopathy (CATO)
Roberto Bolli · University Of Louisville Research Foundation, Inc.
2023–2026 · grant · ALSRP
Development of Clinical Biomarkers for Molecular Subtypes of Sporadic ALS
Molly Gale Hammell · New York University
2023–2026 · grant · VRP
Understanding and Treating TBI-Associated Photophobia with Botulinum Toxin Type A and Its Impact on Visual Function
Anat Galor · Miami, University Of, Coral Gables
2023–2027 · grant · NFRP
Tailoring an Online Platform to Promote Evidence-Based Care in Children and Adults with Neurofibromatosis 1 to Address Medical and Social Barriers to Care
Vanessa Merker · Massachusetts General Hospital
2023–2025 · grant · PRMRP
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Oral Allopregnanolone (LYT-300) for the Treatment of Premutation Carriers with FXTAS
Michael Chen · Puretech Health Llc
2023–2026 · grant · ALSRP
Clinical Development of ISGylation Diagnostic Biomarker for ALS
Shyamal Desai · Louisiana State University Health Sciences Center New Orleans
2023–2026 · grant · DMRDP
A Phase 1 Randomized, Placebo-Controlled, Single Ascending Dose Study to Examine the Safety, Tolerability, and Pharmacokinetics of cNP8 in Healthy Adults
Richard Clark · Neomatrix Therapeutics, Inc.
2023–2027 · grant · TBIPH
Promoting Rapid Return to Functioning After Acute Stress Reaction: Assessing the Efficacy of the iCOVER Intervention
Samuel Mclean · North Carolina At Chapel Hill, University Of
2023–2025 · grant · ALSRP
Identification of a Novel Therapeutic Target and Strategy for C9-ALS
Nicolas Charlet-Berguerand · Ctre Europeen De Recherche En Biologie Et En Medecine
2023–2025 · grant · TSCRP
Mechanisms of Seizure-Induced Death of TSC Model Mice
Ian Wenker · Virginia, University Of
2023–2026 · grant · PRCRP
Noninvasive, Saliva-Based Assay for Screening and Surveillance of Patients with Oral Cavity Squamous Cell Carcinoma (OCSCC)
Evgeny Izumchenko · Chicago, University Of
2023–2027 · grant · OCRP
The Ovarian Cancer Observatory: Prevention, Impact, and Learning from Opportunistic Salpingectomy
David Huntsman · Provincial Health Services Authority
2023–2026 · grant · PRCRP
Promoting Self-Management in Head and Neck Cancer Survivors with Lymphedema and Fibrosis (PROMISE Trial)
Jie Deng · Pennsylvania, University Of
2023–2026 · grant · OCRP
Regulation of Fallopian Tube Epithelial Cells and Ovarian Cancer Initiation from Them by a Stromal Niche
Zhe Li · Brigham And Women's Hospital, Inc.
2023–2027 · grant · ERP
Post-Traumatic Epilepsy Center Without Walls (PTEC WoW)
Mary Jo Pugh · Utah, University Of
2023–2026 · grant · PCRP
Targeting Prostate Cancer Metabolic Vulnerabilities in the Bone Microenvironment to Circumvent Lethal Metastatic Disease
Hai Wang · Health Research Inc., Roswell Park Division
2023–2027 · grant · PRMRP
IND-Enabling Studies for Targeted Phase Shift Microbubbles for Sonothrombolysis
Emmanuelle Meuillet · Microvascular Therapeutics, Llc
2023–2026 · grant · RTR
A Multimodal Approach to Reduce VCA Immunogenicity and Improve Functional Outcome
George Bittner · Texas, University Of, At Austin
2023–2026 · grant · KCRP
Multifunctional Immunotherapy Nanoparticle to Enable Innate Immunotherapy for Kidney Cancer
Andrew Wang · Texas, University Of, Southwestern Medical Center At Dallas
2023–2025 · grant · LCRP
UCHL1 is a Novel Minimally Invasive Molecular Indicator and Therapeutic Target for Small Cell Lung Cancer
Tanya Stoyanova · California, University Of, Los Angeles, David Geffen School Of Medicine
2023–2026 · grant · LRP
Understanding Glucose Metabolism in the Development and Treatment of Lupus
Lucas Chang · Jackson Laboratory
2023–2026 · grant · PRP
Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease (PD-CFI)
Deepak Gupta · Vermont & State Agricultural College, University Of
2023–2026 · grant · TBIPH
microRNA Biomarkers of Cumulative Blast-Mild Traumatic Brain Injury (Micro BCB)
James Meabon · Va Puget Sound Health Care System
2023–2026 · grant · ALSRP
Using CSF1R Suppression to Reprogram Microglia to a Neuroprotective State in ALS
Justin Ichida · University of Southern California
2023–2026 · grant · DMDRP
Enhanced Gene Therapy for DMD Using Larger Dystrophins and Lower Vector Doses
Jeffrey Chamberlain · Washington, University Of
2023–2026 · grant · RCRP
Identifying Novel Compounds for Treatment of pdChordoma and Other SMARCB1-Deficient Rare Tumors
Sanjay Malhotra · Oregon Health And Science University - Portland
2023–2027 · grant · PRCRP
Genomic and Immunomic Mechanisms of Resistance During Daratumumab Post Stem Cell Transplantation in Patients with Poor-Risk T-Cell Lymphoblastic Lymphoma/Leukemia
David Teachey · Children's Hospital, Philadelphia
2023–2026 · grant · BCRP
Targeting a Lipid Kinase Regulator of Nuclear Akt in Breast Cancer
Vincent Cryns · Wisconsin, University Of, Madison
2023–2027 · grant · PRCRP
Combination Therapy for Cancer Related Fatigue in Patients with Metastatic Cancers
Sriram Yennu · M.d. Anderson Cancer Center, University Of Texas
2023–2026 · grant · ALSRP
RP-115: A Novel Biomarker of Astrocyte Dysfunction and Glutamate Dysregulation in Brain and Spinal Cord in ALS
Michael Osullivan · The University of Queensland